Anne-France est spécialisée en droit des affaires avec un focus spécifique dans le domaine des sciences de la vie.
Elle conseille des laboratoires pharmaceutiques, sociétés de biotechnologie, fonds d’investissement spécialisés et autres acteurs dans la santé dans le cadre de leurs opérations de M&A, d’investissement, de partenariats ainsi que lors de la négociation de leurs accords stratégiques en France et à l’étranger.
Avant de rejoindre McDermott, Anne-France a exercé au sein de cabinets d’avocats internationaux.
Formation
Université Paris I Panthéon-Sorbonne, Licence de Droit privé, 2006
Université Paris I Panthéon-Sorbonne, Master 1 de Droit des affaires, 2007
Université Paris V, Descartes, Master 2 de Droit des affaires et de Droit européen, 2008
Counsel | Paris
Paris: +33 1 81 69 15 53
Paris: +33 1 81 69 15 15
Paris, France / McDermott Event / June 19, 2018
1
Law 360 / November 20, 2018
Press Releases / October 26, 2018
McDermott Advises Innate Pharma in Expanding its Collaboration with AstraZeneca
Paris / Le Monde du Droit / January 17, 2018
Paris / Global Legal Chronicle / December 27, 2017
Sensorium Signs Collaboration Agreement with Cochlear Limited
Paris / Le Monde du Droit / December 26, 2017
Paris / Press Releases / Décembre 20, 2017
McDermott aux côtés de Sensorion dans sa collaboration avec Cochlear ...
Paris / Le Monde du Droit (France) / March 17, 2017
Paris / Legal Monitor / March 17, 2017
McDermott Advised Servier on its Partnership with Neurochlore
Paris / Le Monde du Droit (France) / March 16, 2017
Paris / Press Releases / 15 Mars 2017
McDermott Will & Emery Conseille Servier dans le cadre de son Partenariat avec ...
Paris / Press Releases / 22 Novembre 2016
McDermott Will & Emery conseille Poietis dans le cadre d’un partenariat avec ...
La Lettre des Juristes d’Affaires (France) / January 18, 2016
McDermott and Jones Day Advise on the Licensing Agreement Between Innate Pharma ...
Le Monde du Droit / January 13, 2016
Paris / Press Releases / December 3, 2015
McDermott Advises Servier on Strategic Agreement with Cellectis
Le Monde du Droit (France) / November 25, 2015
Press Releases / November 19, 2015
McDermott Advises Pierre Fabre on Framework of Collaboration Agreement Entered into with ...
Le Monde du Droit (France) / November 18, 2015
Décideurs Stratégie Finance Droit (France) / November 17, 2015
Pierre Fabre and Array BioPharma Announce Collaboration in Oncology
Law in France / November 17, 2015
McDermott Advises Pierre Fabre on Cooperation Agreement with Array BioPharma
Le Monde du Droit (France) / June 9, 2015
Law in France / June 8, 2015
Capital Finance (France) / June 1, 2015
Le Monde du Droit (France) / December 19, 2014
Le Monde du Droit (France) / September 22, 2014
1
2
3
4
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.